Therapy in Neuro-Oncology
This special issue belongs to the section "Cancer Therapy".
Special Issue Information
Dear Colleagues,
The therapeutic landscape of neuro-oncology continues to evolve rapidly despite profound therapeutic challenges. Advances in cancer neuroscience, increasingly refined molecular classification of primary central nervous system tumors, and the development of novel therapies are reshaping patient care. This Special Issue highlights these developments across both adult and pediatric populations. Topics include updates on important areas such as IDH inhibitor therapy and therapeutic strategies in cancer neuroscience, as well as emerging data on immunotherapies such as CAR-T and cancer vaccines. There are also contributions on molecular diagnosis and management of meningiomas, along with evolving diagnostic and management strategies for metastatic disease, including brain metastases and leptomeningeal disease. Finally, advances in modern technology and supportive care highlight a growing emphasis on precision medicine, multidisciplinary care, and patient-centered outcomes in neuro-oncology.
Dr. Herbert B. Newton
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glioma
- IDH inhibitor
- CAR-T
- primary CNS lymphoma
- cancer neuroscience
- brain metastasis
- leptomeningeal disease
- molecular classification
- pediatric and AYA brain tumors
- liquid biopsy
- AI
- radiation
- supportive care
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

